ISG15 and hepatocellular carcinoma: Intriguingly, STNvac promotes the formation of tertiary lymphoid structures (TLSs) through GZMA-F2R-mediated interactions between ISG15<sup>+</sup> CD8<sup>+</sup> T cells and antigen-presenting cells (APCs), which is also confirmed in HCC patients.